Quest Diagnostics 1997 Annual Report Download - page 17

Common Stock
Shares of Quest Diagnostics
Incorporated common stock (ticker
symbol: ÒDGXÓ) are listed on the New
York Stock Exchange and also trade on
the Stuttgart (Germany) Stock Exchange.
Options on Quest Diagnostics shares are
traded on the Chicago Board Options
Exchange.
Corporate Headquarters
One Malcolm Avenue
Teterboro, New Jersey 07608
201-393-5000
Annual Meeting
The first annual meeting of Quest
Diagnostics shareholders will be held on
May 12, 1998, in New York City. A proxy
statement and annual report were
mailed to shareholders of record as of
March 16, 1998.
Additional Information
All inquiries should be addressed to:
Investor Relations Department
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, New Jersey 07608
201-393-5030
Shareholders may call the Quest
Diagnostics Investor News and
Information Line toll-free at:
888-DGX-0002.
Annual Report on Form 10-K
A copy of the Quest Diagnostics
1997 Annual Report on Form 10-K,
filed with the Securities and Exchange
Commission, is contained in this Annual
Report, starting after page 16. Additional
copies are available without charge by
contacting the Investor Relations
Department.
Internet Access
Corporate news releases, our annual
report, Forms 10-K and 10-Q and other
information about the company are
available through Quest DiagnosticsÕ
web site on the Internet. It may be
accessed at the following address:
http://www.questdiagnostics.com.
Transfer Agent and Registrar
Harris Trust and Savings Bank
Shareholder Services Division
P.O. Box 755
Chicago, Illinois 60690-0755
Telephone: [phone]
For the hearing impaired, Harris Bank
has a Telecommunication Device for the
Deaf (TDD) telephone. The listing is
Harris Bank Hearing Impaired
Telephone
TDD 312-461-5633 or
TDD 312-461-5637.
Report change of address to Harris Trust
and Savings Bank at the above address.
No dividends have been declared
on common stock.
ÔSafe HarborÕ Statement under the Private
Securities Litigation Reform Act of 1995
The statements in this Annual Report
which are not historical facts or
information are forward-looking
statements. These forward-looking
statements involve risks and
uncertainties that could cause the
outcome to be materially different.
Certain of these risks and uncertainties
are listed in the 1997 Annual Report
on Form 10-K contained in this Annual
Report. These risks and uncertainties
include heightened competition,
impact of changes in payor mix, adverse
actions by governmental and other
third-party payors, the impact upon
Quest DiagnosticsÕ collection rates or
general or administrative expenses
resulting from compliance with
Medicare administrative policies,
adverse results from pending
governmental investigations, reduction
in tests ordered by existing customers,
material increases in premiums for
insurance coverage, denial of licensure,
computer or other system failures,
development of technologies that
substantially alter the practice of
medicine and changes in interest rates.
15
ANSWERS FOR INVESTORS